From: bco-bounces@lists.oulu.fi [mailto:bco-bounces@lists.oulu.fi] On Behalf Of anita.tienhaara@helsinki.fi
Sent: 2. marraskuuta 2009 10:41
To: FinBioNet
Subject: [Bco] Nordic EMBL Partnership is seeking outstanding international candidates for the positions of PhD Students in Molecular Medicine

 

Nordic EMBL Partnership for Molecular Medicine

 

The Nordic EMBL Partnership for Molecular Medicine was established in 2007 as a joint venture between the European Molecular Biology Laboratory (EMBL) and the Universities of Helsinki, Finland, Oslo, Norway and Umeå, Sweden and involves building of national sister institutions in the three countries. The partnership between EMBL, the Institute for Molecular Medicine Finland (FIMM), the Centre for Molecular Medicine Norway (NCMM) and the Laboratory for Molecular Infection Medicine Sweden (MIMS) is dedicated to the growing field of life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments. Aiming to combine complementary strengths in the Nordic EMBL Partnership each partner brings in a unique set of expertise, skills and facilities encompassing EMBL’s recognized research strengths in the areas of molecular, cellular and developmental biology, bioinformatics and structural biology complemented by Norway’s expertise in molecular mechanisms of disease, Sweden’s focus on microbial pathogenicity and molecular infection medicine and Finland’s strength in human genomics and medical systems biology which equip the partners to tackle some of the most challenging problems of biomedicine. The Partnership provides access to scientific infrastructure, including databases, facilities and instrumentation, as well as to clinical materials and networks and training activities provided by the partners and adopts the EMBL model for international recruitment, staff turnover and scientific reviews.

 

The Nordic EMBL Partnership is now seeking outstanding international candidates for the positions of PhD Students in Molecular Medicine.

 

FIMM: Helsinki, Finland

> Molecular Medicine

 

MIMS: Umeå, Sweden

> Molecular Infection Medicine

 

NCMM: Oslo, Norway

> Molecular Medicine – Disease Mechanisms

 

For further details and more comprehensive job descriptions please visit the websites of FIMM (www.fimm.fi), NCMM (www.ncmm.uio.no) and MIMS (www.mims.se) . Applications for all positions should be sent electronically following the instructions given by the institutes’ websites.

 

The submission deadline is 15 December 2009 .

 

 

-------------------------------------------

This message was sent to you by FinBioNet

Anita Tienhaara

Institute of Biotechnology

P.O. Box 56

FIN-00014 University of Helsinki, finland

tel. +358 9 191 59656

fax +358 9 191 59550

anita.tienhaara@helsinki.fi